| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC2696 |
| Trial ID | NCT04897321 |
| Disease | Rhabdomyosarcoma | Neuroblastoma | Germ Cell Cancer | Ewing Sarcoma | Carcinoma | Adrenocortical Carcinoma | Osteosarcoma | Rhabdoid Tumor | Hepatoblastoma | Desmoplastic Small Round Cell Tumor | Melanoma | Peripheral Nerve Sheath Neoplasm | Childhood Soft Tissue Sarcoma | Clear Cell Sarcoma | Wilms' Tumor |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B7-H3 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) |
| Year | 2021 |
| Country | United States |
| Company sponsor | St. Jude Children's Research Hospital |
| Other ID(s) | 3CAR |
| Cohort 1 | |||||||||||
|
|||||||||||